Skip to content

Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment

Safety and Performance of the SpineVision Posterior Fixation Systems Lumis®, Plus® and Ulis® in Thoracolumbar Spinal Degenerative Pathologies or Degenerative Disc Disease (DDD) Associated Pathologies Treatment - Fixed D3 Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06342765
Acronym
FixedD3
Enrollment
330
Registered
2024-04-02
Start date
2022-09-22
Completion date
2028-05-30
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervertebral Disc Degeneration

Keywords

Lumbar, Spine, Fusion, Posterior fixation, Oswestry disability index, Visual Analogue Score

Brief summary

The goal of this observational study is to confirm the safety and performance of the three (3) Spinevision posterior fixations systems Lumis®, Plus® and Ulis® , in the treatment of patient suffering from thoracolumbar spinal degenerative pathologies, or degenerative disc disease (disease that occurs when the spinal disk break down) associated pathologies. Part of their standard of care, participants will be questioned on their back and leg pains, their disability and if they have encountered any adverse effects since the Spinevision posterior fixation system implant surgery. Those data will be collected up to twenty four (24) months after the Spinevision posterior fixation system implant surgery.

Detailed description

The Fixed D3 study is a multicentric, non-randomized, ambispective, post market clinical follow-up study. This means that either subjects already implanted with one (1) of the Spinevision posterior fixations systems (Lumis, Plus or Ulis) - retrospective subjects - or subjects planned for treatment with one of the Spinevision posterior fixation system (prospective subjects) can be enrolled in the study. Standard of care data up to twenty four (24) months post Spinevision posterior fixation system implant procedure will be collected; key data include back and leg Visual Analogue Score (VAS) pain, Oswestry Disability Index (ODI) score, and adverse events. Data will be collected at pre-operative, per-operative, and post-operative Month 2, Month 6, Month 12 and Month 24.

Interventions

DEVICEPedicle fixation surgery

Pedicle fixation surgery indicates a surgical approach in the thoracic spine down to sacral spine to either support interbody fusion (fusion of the discal space between two vertebrae) , or to correct spinal deformity.

Sponsors

SPINEVISION SAS
Lead SponsorINDUSTRY
Slb Pharma
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient implanted with Lumis®, Plus® or Ulis® posterior fixation system * Patient of 18 years old and more * Patient has provided signed informed consent or did not oppose to his/her data collection, per local regulation

Exclusion criteria

contra-indication * trauma (i.e., fracture or dislocation) * Known or suspected allergy or intolerance to the implanted material, mainly to metal (e.g., cobalt, chromium, nickel, etc.) * Any other medical or surgical condition likely to compromise the success of instrumented surgery, such as the presence of a malignant tumor or serious congenital abnormalities, raised erythrocyte sedimentation rate not explained by other diseases, high white blood cell count or a tendency to low white blood cell count * All cases not described in the indications * Localized infection of the operative site * All patients with insufficient tissue cover of the operative site * Local signs of inflammation * Fever or leukocytosis * Pathological obesity * Pregnancy * Mental illness * Rapidly evolving joint diseases, bone absorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this medical condition can limit the expected correction gain and stability of mechanical fixation * All cases not requiring bone graft or bone fusion * When pedicular screws are used, absence or malformation of pedicles * All cases requiring a combination of different metals * All patients not agreeing to comply with post-operative instructions

Design outcomes

Primary

MeasureTime frameDescription
Incidence of serious and non-serious device- and/or procedure-related adverse eventsMonth 24Rate of the serious and non-serious device- and/or procedure-related adverse events will be analyzed and compared to the state of the art.
Change of the Oswestry Disability Index (ODI)Month 12Oswestry Disability Index (ODI) mean score at Month 12 will be compared to the ODI mean score at baseline.

Secondary

MeasureTime frameDescription
Fusion successMonth 2, month 6, month 12 and month 24Fusion rate will be analyzed and compared to the state if the art.
Change of the Oswestry Disability Index (ODI)Month 2, month 6, month 12 and month 24Mean Oswestry Disability Index (ODI) score evolution score will be analyzed.
Change of the back and leg Visual Analogue Score (VAS)Month 2, month 6, month 12 and month 24Back and leg Visual Analogue Score (VAS) pain assessment will be analyzed.
Incidence of revision surgery at implant siteMonth 2, month 6, month 12 and month 24Rate of revision surgery at implant site will be analyzed and compared to the state of the art.

Countries

France

Contacts

CONTACTRenaud Duchenes
r.duchenes@spinevision.com+33 6 86 16 61 91
CONTACTHanta Ranaivoson
h.ranaivoson@spinevision.com
PRINCIPAL_INVESTIGATORBenjamin Pommier

Orthéo Neurochirurgie

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026